Home
About
Overview
Sharing Data
ORCID
Help
History (4)
Challenges to Door-In-Door-Out Time Thresholds for Patients With Stroke-Reply.
Combination cediranib and olaparib versus olaparib alone for women with recurrent platinum-sensitive ovarian cancer: a randomised phase 2 study.
Lung-specific loss of the laminin a3 subunit confers resistance to mechanical injury.
Pituitary adenoma and bilateral male breast cancer: an unusual association.
See All 4 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Challenges to Door-In-Door-Out Time Thresholds for Patients With Stroke-Reply.
Challenges to Door-In-Door-Out Time Thresholds for Patients With Stroke-Reply. JAMA. 2023 12 19; 330(23):2306.
View in:
PubMed
subject areas
Brain Ischemia
Humans
Stroke
Thrombolytic Therapy
Time-to-Treatment
Tissue Plasminogen Activator
authors with profiles
Shyam Prabhakaran